Subcutaneous heparin treatment increases survival in small cell lung cancer

Cancer

Volumn 74, Issue 1, 1994, Pages 38-45

  Lebeau, Bernard ^a   Chastang, Claude ^b   Brechot, Jeanne‐Marie ^c   Capron, Frédérique ^c   Dautzenberg, Berteand ^d   Delaisements, Corinne ^e   Mornet, Michel ^f   Brun, Janine ^g   Hurdebourcq, Jean‐Paul ^h   Lemarie, Etienne ⁱ  

^a HÔPITAL SAINT ANTOINE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔTEL DIEU   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

^f Service de Pneumologie CH Jacques C ur   (France)

^g CAEN UNIVERSITY HOSPITAL   (France)

^h CENTRE HOSPITALIER DE TROYES   (France)

ⁱ CHU BRETONNEAU   (France)

Author keywords

blood coagulation; chemotherapy; heparin; randomized trials; small cell lung cancer

Indexed keywords

ARTICLE; BLOOD CLOTTING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPARINIZATION; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE; THROMBOCYTE COUNT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEPARIN; HUMANS; INJECTIONS, SUBCUTANEOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0028239146     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E     Document Type: Article

References (24)

1. Malignancy and haemostasis
2. Effect of warfarin anticoagulation on survival in carcinoma of the lung colon, head and neck and prustate: final report of VA Cooperative study 75
3. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small cell lung cancer by the Cancer and Leukemia Group B
4. Potential role of platelets in the pathogenesis of tumor metastasis
5. No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy: results from a randomized clinical trial of 303 patients
6. Aspirin use and reduced risk of fatal colon cancer
7. A randomized trial of delayed thoracie radiotherapy in complete responder patients with small cell lumg cancer
8. Palnning the size and duration of a clinical trial studying the time to some critical event
9. Non parametric estimation from incomplete observations
10. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II: analysis and examples
11. Anticoagulants in the treatment of small cell carcinoma of the bronchus
12. Heparin and chemotherapy in the management of inoperable lung carcinoma
13. Heparin and polychemotherapy for treatment of lung cancer
14. Rationale and experimental design for the VA Cooperative Study of anticoagulation (warfarin) in the treatment of cancer
15. Activation of blood coagulation in cancer: Trousseau's syndrome revisited
16. Données cliniques et paracliniques initiales des 304 cancers bronchopulmonaires à petites cellules de I'essai 01PC83
17. Thrombin‐specific sites of fibrinogen in small cell carcinoma of the lung
18. +
19. Identification of a thrombin‐sequence with growth factor activity on macrophages
20. Alpha‐thrombin induced early mitogenic signalling events and Go to S‐phase transition of fibroblasts require continual external stimulation
21. Modulation of endothelial cells growth induced by heparin
22. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisons
23. A new class of steroids inhibits angiogenesis in the presence of heparing or a heparin fragment
24. Crokinase combination chemotherapy in small cell lung cancer